Not Yet Recruiting
The Efficacy and Safety of Trastuzumab Deruxtecan in Advanced or Metastatic NSCLC With HER2 Over Expression
NCT07662473
- Conditions
- NSCLC
- Locations
-
Not specified
Clinical trial condition
Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.
NCT07662473
Not specified
NCT07358689
NCT07643350
NCT07622706
Not specified
NCT07376382
Not specified
NCT07379398
NCT07550920
Not specified
NCT07158489
NCT07530744
NCT07516015
Not specified